Regeneron Pharmaceuticals Inc. v Alvotech Hf. & Anor

Regeneron Pharmaceuticals Inc. v Alvotech Hf. & Anor

The court directed that the trial be expedited to start on 3rd November, finding that an earlier date was not feasible due to substantive and procedural concerns, including the need to address proportionality and delay arguments regarding injunctive relief.

Parties
Claimant: Regeneron Pharmaceuticals, Inc.; Defendant: Alvotech Hf.; Defendant: Fisher Clinical Services UK Limited
Jurisdiction
England and Wales
Judgment Date
15 October 2025
Procedural Posture
Patent / Application for Expedition
Outcome
application for expedition granted in part
Legal Topics
Expedition of Trial, Injunctions, Proportionality, Delay in Seeking Relief
Intellectual Property Patents Expedition of Trial Injunctions Proportionality Delay in Seeking Relief

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Party arguments 2
Sign in to unlock

Parties

Regeneron Pharmaceuticals, Inc.

Claimant

Alvotech Hf.

Defendant

Fisher Clinical Services UK Limited

Defendant

Procedural Posture

Patent / Application for Expedition

Legal Issues

  1. 1 Whether the trial should be expedited
  2. 2 Whether the parties' agreement to expedition is sufficient
  3. 3 Whether an injunction should be refused for disproportionality or delay

Ratio Decidendi

The court directed that the trial be expedited to start on 3rd November, finding that an earlier date was not feasible due to substantive and procedural concerns, including the need to address proportionality and delay arguments regarding injunctive relief.

Court Disposition

application for expedition granted in part

Orders

  • Trial to be heard on an expedited basis starting 3rd November
  • Two days allocated for the hearing